Market Overview:
The global melitracen market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of anxiety disorders and increasing demand for melitracen from hospital and drug store applications. However, stringent regulatory policies and high cost of research & development are some of the major factors restraining the growth of this market. Based on type, the global melitracen market is segmented into single drug preparations and mixture drug preparations. The single drug preparations segment is further sub-segmented into oral tablets/capsules and injectables. In terms of application, the global melitracen market is divided into hospital pharmacies and retail pharmacies (drug stores). Geographically, North America dominates the global melitracen market followed by Europe due to rising prevalence rates for anxiety disorders in these regions.
Product Definition:
A drug used to treat depression.
Single Drug Preparations:
Single drug preparations are the most preferred and extensively used pharmaceutical formulations. They are available in various forms such as solid, semi-solid, liquid and solution. Single drug preparation is specifically designed for a specific disease condition or medical problem.
Mixture Drug Preparations:
Mixture drug preparations are generic name for drugs that contain more than one active ingredient. They can be divided into two categories, first category includes combination of active ingredients which have been used as separate medicines and the second category consists of unique formulations which have not been marketed separately before.
Application Insights:
Based on the application, the global melitracen market is segmented into hospital and drug store. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as increasing number of tuberculosis cases across various regions coupled with rising awareness about TB treatment and diagnosis is one of the key factors responsible for this growth. According to WHO, an estimated 10 million people were diagnosed with TB worldwide in 2016 which resulted in an estimated 1.6 million deaths due to its complications that same year alone which paves way for lucrative opportunities for pharmaceutical companies involved in R&D pertaining to melitracen therapy thereby contributing towards overall market growth at a significant rate over the forecast period.
Drug stores are anticipated to witness substantial growth during the forecast period owing to growing awareness among consumers regarding their health conditions along with rising incidences of diabetes-related diseases such as diabetic retinopathy.
Regional Analysis:
In 2017, North America dominated the global melitracen market with a revenue share of around 37.0%. The growth is attributed to the rising prevalence of chronic diseases such as cancer and cardiovascular diseases in this region. In addition, increasing R&D activities by various companies for developing novel drugs is also one of the major factors responsible for its dominance. For instance, Sun Pharma has developed new formulations for its existing drug Melicor (melatonin) tablets that are used to treat insomnia and sleep disorders like sleep apnea & narcolepsy.
However, Asia Pacific region is expected to witness lucrative growth during the forecast period owing to growing awareness about health issues due melatonin deficiency syndrome among children leading towards an increase in demand from countries like India & China etc.
Growth Factors:
- Increasing demand for antidepressants in the developed countries
- Rising geriatric population susceptible to mental disorders
- Growing awareness about mental health and its treatment options
- Availability of melitracen in generic form
- Novel indications for melitracen being explored
Scope Of The Report
Report Attributes
Report Details
Report Title
Melitracen Market Research Report
By Type
Single Drug Preparations, Mixture Drug Preparations
By Application
Hospital, Drug Store
By Companies
Lundbeck, General Pharma, Rangs Group, Unimed and Unihealth, Drug International, Somatec Pharmaceuticals, Mankind Pharma, Molekule, Helios Pharmaceutical, East West Pharma, Union Medical, Aristopharma, Bio-Pharma, ACI Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Melitracen Market Report Segments:
The global Melitracen market is segmented on the basis of:
Types
Single Drug Preparations, Mixture Drug Preparations
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lundbeck
- General Pharma
- Rangs Group
- Unimed and Unihealth
- Drug International
- Somatec Pharmaceuticals
- Mankind Pharma
- Molekule
- Helios Pharmaceutical
- East West Pharma
- Union Medical
- Aristopharma
- Bio-Pharma
- ACI Pharmaceuticals
Highlights of The Melitracen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Drug Preparations
- Mixture Drug Preparations
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Melitracen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Melitracen is a medication used to treat skin infections. It is a topical antibiotic that is applied to the skin. Melitracen works by killing bacteria on the skin surface.
Some of the major players in the melitracen market are Lundbeck, General Pharma, Rangs Group, Unimed and Unihealth, Drug International, Somatec Pharmaceuticals, Mankind Pharma, Molekule, Helios Pharmaceutical, East West Pharma, Union Medical, Aristopharma, Bio-Pharma, ACI Pharmaceuticals.
The melitracen market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Melitracen Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Melitracen Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Melitracen Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Melitracen Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Melitracen Market Size & Forecast, 2018-2028
4.5.1 Melitracen Market Size and Y-o-Y Growth
4.5.2 Melitracen Market Absolute $ Opportunity
Chapter 5 Global Melitracen Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Melitracen Market Size Forecast by Type
5.2.1 Single Drug Preparations
5.2.2 Mixture Drug Preparations
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Melitracen Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Melitracen Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Melitracen Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Melitracen Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Melitracen Analysis and Forecast
9.1 Introduction
9.2 North America Melitracen Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Melitracen Market Size Forecast by Type
9.6.1 Single Drug Preparations
9.6.2 Mixture Drug Preparations
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Melitracen Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Melitracen Analysis and Forecast
10.1 Introduction
10.2 Europe Melitracen Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Melitracen Market Size Forecast by Type
10.6.1 Single Drug Preparations
10.6.2 Mixture Drug Preparations
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Melitracen Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Melitracen Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Melitracen Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Melitracen Market Size Forecast by Type
11.6.1 Single Drug Preparations
11.6.2 Mixture Drug Preparations
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Melitracen Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Melitracen Analysis and Forecast
12.1 Introduction
12.2 Latin America Melitracen Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Melitracen Market Size Forecast by Type
12.6.1 Single Drug Preparations
12.6.2 Mixture Drug Preparations
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Melitracen Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Melitracen Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Melitracen Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Melitracen Market Size Forecast by Type
13.6.1 Single Drug Preparations
13.6.2 Mixture Drug Preparations
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Melitracen Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Melitracen Market: Competitive Dashboard
14.2 Global Melitracen Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lundbeck
14.3.2 General Pharma
14.3.3 Rangs Group
14.3.4 Unimed and Unihealth
14.3.5 Drug International
14.3.6 Somatec Pharmaceuticals
14.3.7 Mankind Pharma
14.3.8 Molekule
14.3.9 Helios Pharmaceutical
14.3.10 East West Pharma
14.3.11 Union Medical
14.3.12 Aristopharma
14.3.13 Bio-Pharma
14.3.14 ACI Pharmaceuticals
